ArticleCureus2025
An Unusual Presentation of T-cell/Histiocyte-Rich B-cell Lymphoma: A Diagnostic Challenge.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Necrotizing masses pose a remarkable diagnostic challenge as they masquerade as infections, ischemic events, malignancies, autoimmune conditions, etc. Herewith, we are discussing a rare presentation of a man in his early 40s who presented with a necrotizing mass in the anterior chest wall and underwent multiple evaluations resulting in several initial misdiagnoses before the definitive diagnosis of T-cell/histiocyte-rich B-cell lymphoma was made. The patient was initiated on the R-CHOP (rituximab, cyclophosphamide, Doxorubicin, Vincristine, and prednisone) regimen and is currently under therapy. This case report highlights the significance of the diagnostic approach with thorough histopathological and immunohistochemical evaluation to diagnose unusual presentations, for appropriate management, and improving patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.